{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:03Z","timestamp":1761745623103},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,6]]},"DOI":"10.7759\/cureus.26617","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T02:53:40Z","timestamp":1657162420000},"source":"Crossref","is-referenced-by-count":3,"title":["An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica"],"prefix":"10.7759","author":[{"given":"Anam","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donica L","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani C","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002, 347:261-71. 10.1056\/NEJMra011913","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19152","article-title":"Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review","volume":"7","author":"Bassendine MF","year":"2019","unstructured":"Bassendine MF, Bridge SH. Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review. Eur J Rheumatol. 2019, 7:37-40. 10.5152\/eurjrheum.2019.19152","journal-title":"Eur J Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105282","article-title":"SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: \"Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\" by Manzo et al. Joint Bone Spine 2021;88:105150","volume":"89","author":"Cadiou S","year":"2022","unstructured":"Cadiou S, Perdriger A, Ardois S, et al.. SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: \"Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\" by Manzo et al. Joint Bone Spine 2021;88:105150. Joint Bone Spine. 2022, 89:105282. 10.1016\/j.jbspin.2021.105282","journal-title":"Joint Bone Spine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali RA","year":"2021","unstructured":"Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021, 106:376-81. 10.1016\/j.ijid.2021.04.047","journal-title":"Int J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref6","article-title":"Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study","volume":"26","author":"Duhaut P","year":"1999","unstructured":"Duhaut P, Bosshard S, Calvet A, et al.. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. J Rheumatol. 1999, 26:361-9.","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review","volume":"20","author":"Liozon E","year":"2021","unstructured":"Liozon E, Parreau S, Filloux M, et al.. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review. Autoimmun Rev. 2021, 20:102732. 10.1016\/j.autrev.2020.102732","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.03.007","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases","volume":"203","author":"Watad A","year":"2019","unstructured":"Watad A, Bragazzi NL, McGonagle D, et al.. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases. Clin Immunol. 2019, 203:1-8. 10.1016\/j.clim.2019.03.007","journal-title":"Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab756","article-title":"Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study","volume":"61","author":"Mettler C","year":"2022","unstructured":"Mettler C, Jonville-Bera AP, Grandvuillemin A, Treluyer JM, Terrier B, Chouchana L. Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. Rheumatology (Oxford). 2022, 61:865-7. 10.1093\/rheumatology\/keab756","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang TY","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982, 97:672-80. 10.7326\/0003-4819-97-5-672","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64714-9","article-title":"Polymyalgia rheumatica","volume":"348","author":"Salvarani C","year":"1996","unstructured":"Salvarani C, Boiardi L, Macchioni L, Olivieri I, Portioli I. Polymyalgia rheumatica. Lancet. 1996, 348:550-1. 10.1016\/S0140-6736(05)64714-9","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(84)90012-x","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey LA","year":"1984","unstructured":"Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984, 13:322-8. 10.1016\/0049-0172(84)90012-x","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.34356","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta B","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Kremers HM, et al.. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012, 64:943-54. 10.1002\/art.34356","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1178572","article-title":"Recent advances in the diagnosis and treatment of polymyalgia rheumatica","volume":"12","author":"Muratore F","year":"2016","unstructured":"Muratore F, Pazzola G, Pipitone N, Salvarani C. Recent advances in the diagnosis and treatment of polymyalgia rheumatica. Expert Rev Clin Immunol. 2016, 12:1037-45. 10.1080\/1744666X.2016.1178572","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100523-an-unusual-side-effect-of-the-covid-19-vaccine-a-possible-trigger-of-polymyalgia-rheumatica","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:05Z","timestamp":1707507545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100523-an-unusual-side-effect-of-the-covid-19-vaccine-a-possible-trigger-of-polymyalgia-rheumatica"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.26617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,6]]}}}